Neuroleptic malignant syndrome
Neurology
Illness script · Neurology
Neuroleptic malignant syndrome
Life-threatening hyperdopaminergic blockade reaction to antipsychotics causing hyperthermia, rigidity, autonomic instability, and altered mental status.
This illness script for Neuroleptic malignant syndrome covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.
01
Predisposing factors
- Typical antipsychotics (haloperidol) > atypicals; any dopamine antagonist (metoclopramide, promethazine)
- Abrupt withdrawal of dopaminergic agents (levodopa, amantadine) in Parkinson's patients
- Rapid dose escalation or high-potency agent initiation
- Dehydration, agitation, and high ambient temperature increase risk
- Young males slightly overrepresented; no strong genetic predisposition identified
02
Presentation
- Classic tetrad: hyperthermia (>38°C), lead-pipe rigidity, altered mental status, autonomic instability
- Onset hours to days after starting or increasing offending agent; full syndrome in 24–72 h
- AMS precedes or accompanies rigidity — ranges from confusion to coma
- Autonomic findings: diaphoresis, tachycardia, labile BP, tachypnea
- 'Lead-pipe' rigidity (uniform resistance throughout ROM) is pathognomonic quality
- Fever is HIGH, often >40°C; distinguishes from many other drug reactions
03
Pathophysiology
- Central D2 receptor blockade in hypothalamus → loss of thermoregulation → hyperthermia
- D2 blockade in basal ganglia → profound 'lead-pipe' muscular rigidity
- Rigidity + hyperthermia → rhabdomyolysis → elevated CK, renal failure
- Autonomic instability from disrupted hypothalamic and peripheral dopamine signaling
04
Diagnostics
- No single confirmatory test — clinical diagnosis based on tetrad after drug exposure
- CK markedly elevated (often >1000 U/L); reflects rhabdomyolysis severity
- CBC: leukocytosis (10,000–40,000); LFTs, BMP for complications
- Urine myoglobin, creatinine to assess renal injury
- LP and head CT to exclude infectious/structural causes if diagnosis uncertain
05
Management
- STOP offending antipsychotic immediately — first and most critical step
- Aggressive IV fluid resuscitation for rhabdomyolysis and fever; cooling measures
- Dantrolene (muscle relaxant) for severe rigidity/hyperthermia — reduces mortality
- Bromocriptine or amantadine (dopamine agonists) to reverse central D2 blockade
- Benzodiazepines for agitation/rigidity adjunct; ICU admission mandatory
- Avoid restarting antipsychotics for ≥2 weeks; consider switch to low-potency atypical if essential
06
Clinical pivots
How to separate this script from the look-alikes that show up on exams and on the wards.
Serotonin syndrome
Hyperreflexia + clonus (not lead-pipe rigidity) and onset within hours; cause is serotonergic agents, not antipsychotics
Malignant hyperthermia
Triggered by inhaled anesthetics/succinylcholine in OR, not antipsychotics; ryanodine receptor mutation
Anticholinergic toxicity
Dry skin/mucous membranes and urinary retention; rigidity absent; CK normal
Meningitis/encephalitis
Rigidity is nuchal (meningeal), not lead-pipe generalized; LP is diagnostic; no antipsychotic exposure required
Keep reading
Full library- Nephrotic SyndromeGlomerular disease causing massive proteinuria (>3.5 g/day) with hypoalbuminemia, edema, and hyperlipidemia/lipiduria.
- OsteomyelitisInfection of bone, most commonly bacterial, causing bone destruction and marrow inflammation; classified as hematogenous, contiguous, or vascular insufficiency.
Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.